Editas Medicine, Inc.
DE ˙ DB ˙ US28106W1036
2,35 € ↑0,04 (1,73%)
2026-06-04
AKTIENPREIS
SecurityDE:8EM / Editas Medicine, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership6,539,082 shares
Ownership 7.90%
BlackRock, Inc. ownership in 8EM / Editas Medicine, Inc.

2025-04-17 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,539,082 shares of Editas Medicine, Inc. (DE:8EM). This represents 7.9 percent ownership of the company. In their previous filing dated 2024-01-24 , BlackRock, Inc. had reported owning 7,838,969 shares, indicating a decrease of -16.58 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2025-04-17 2025-04-17 13G/A 7,838,969 6,539,082 -16.58 7.90 -17.71
2024-01-24 2024-01-24 13G/A 7,338,742 7,838,969 6.82 9.60 -10.28
2023-01-26 2023-01-26 13G/A 7,338,742 7,338,742 0.00 10.70 0.00
2023-01-20 2023-01-20 13G/A 6,982,775 7,338,742 5.10 10.70 4.90
2022-10-07 2022-10-07 13G/A 5,433,376 6,982,775 28.52 10.20 29.11
2022-02-03 2022-02-03 13G/A 5,305,406 5,433,376 2.41 7.90 -7.06
2021-01-29 2021-01-29 13G/A 4,241,198 5,305,406 25.09 8.50 2.41
2020-02-05 2020-02-05 13G/A 3,681,534 4,241,198 15.20 8.30 7.79
2019-02-04 2019-02-04 13G/A 2,672,556 3,681,534 37.75 7.70 26.23
2018-02-01 2018-02-01 13G 2,672,556 6.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F EDITAS MEDICINE COM 28106W103 9,263,312 -83,802 -0.90 22,880 19.41 0.0004
2026-02-12 2025-12-31 13F EDITAS MEDICINE COM 28106W103 9,347,114 1,327,223 16.55 19,162 -31.15 0.0003
2025-11-12 2025-09-30 13F EDITAS MEDICINE COM 28106W103 8,019,891 1,199,037 17.58 27,829 85.46 0.0005
2025-08-12 2025-06-30 13F EDITAS MEDICINE COM 28106W103 6,820,854 130,174 1.95 15,006 93.34 0.0003
2025-05-02 2025-03-31 13F EDITAS MEDICINE COM 28106W103 6,690,680 -617,393 -8.45 7,761 -16.38 0.0002
2025-02-07 2024-12-31 13F EDITAS MEDICINE COM 28106W103 7,308,073 -716,636 -8.93 9,281 -66.08 0.0002
2024-11-13 2024-09-30 13F EDITAS MEDICINE COM 28106W103 8,024,709 242,192 3.11 27,364 -24.71 0.0006
2024-08-13 2024-06-30 13F EDITAS MEDICINE COM 28106W103 7,782,517 -50,264 -0.64 36,344 -37.47 0.0008
2024-05-10 2024-03-31 13F EDITAS MEDICINE COM 28106W103 7,832,781 -6,188 -0.08 58,119 -26.81 0.0014
2024-02-13 2023-12-31 13F EDITAS MEDICINE COM 28106W103 7,838,969 -321,064 -3.93 79,409 24.76 0.0020
2023-11-13 2023-09-30 13F EDITAS MEDICINE COM 28106W103 8,160,033 564,337 7.43 63,648 1.82 0.0018
2023-08-11 2023-06-30 13F EDITAS MEDICINE COM 28106W103 7,595,696 177,334 2.39 62,513 16.23 0.0017
2023-05-12 2023-03-31 13F EDITAS MEDICINE COM 28106W103 7,418,362 79,620 1.08 53,783 -17.38 0.0016
2023-02-13 2022-12-31 13F EDITAS MEDICINE COM 28106W103 7,338,742 355,967 5.10 65,095 -23.84 0.0020
2022-11-14 2022-09-30 13F EDITAS MEDICINE COM 28106W103 6,982,775 258,565 3.85 85,469 7.44 0.0029
2022-08-12 2022-06-30 13F EDITAS MEDICINE COM 28106W103 6,724,210 448,940 7.15 79,547 -33.35 0.0026
2022-05-12 2022-03-31 13F EDITAS MEDICINE COM 28106W103 6,275,270 841,894 15.49 119,355 -17.26 0.0032
2022-02-10 2021-12-31 13F EDITAS MEDICINE COM 28106W103 5,433,376 -10,634 -0.20 144,256 -35.50 0.0037
2021-11-09 2021-09-30 13F EDITAS MEDICINE COM 28106W103 5,444,010 -141,179 -2.53 223,638 -29.31 0.0063
2021-08-11 2021-06-30 13F EDITAS MEDICINE COM 28106W103 5,585,189 -152,187 -2.65 316,346 31.28 0.0088
2021-05-07 2021-03-31 13F EDITAS MEDICINE COM 28106W103 5,737,376 431,970 8.14 240,971 -35.22 0.0071
2021-02-05 2020-12-31 13F EDITAS MEDICINE COM 28106W103 5,305,406 -192,869 -3.51 371,962 141.09 0.0119
2020-11-06 2020-09-30 13F EDITAS MEDICINE COM 28106W103 5,498,275 510,595 10.24 154,282 4.57 0.0057
2020-08-14 2020-06-30 13F EDITAS MEDICINE COM 28106W103 4,987,680 795,631 18.98 147,536 77.48 0.0059
2020-05-01 2020-03-31 13F EDITAS MEDICINE COM 28106W103 4,192,049 -49,149 -1.16 83,128 -33.81 0.0041
2020-02-13 2019-12-31 13F EDITAS MEDICINE COM 28106W103 4,241,198 116,742 2.83 125,582 33.89 0.0048
2019-11-08 2019-09-30 13F EDITAS MEDICINE COM 28106W103 4,124,456 251,925 6.51 93,792 -2.10 0.0039
2019-08-22 2019-06-30 13F/A-1 EDITAS MEDICINE COM 28106W103 3,872,531 84,186 2.22 95,805 3.43 0.0041
2019-08-13 2019-06-30 13F EDITAS MEDICINE COM 28106W103 3,872,531 84,186 95,805
2019-05-09 2019-03-31 13F EDITAS MEDICINE COM 28106W103 3,788,345 106,811 2.90 92,625 10.59 0.0041
2019-02-08 2018-12-31 13F EDITAS MEDICINE COM 28106W103 3,681,534 92,393 2.57 83,755 -26.66 0.0042
2018-11-09 2018-09-30 13F EDITAS MEDICINE COM 28106W103 3,589,141 134,075 3.88 114,207 -7.75 0.0049
2018-08-09 2018-06-30 13F EDITAS MEDICINE COM 28106W103 3,455,066 591,442 20.65 123,796 30.41 0.0057
2018-05-09 2018-03-31 13F EDITAS MEDICINE COM 28106W103 2,863,624 191,068 7.15 94,930 15.59 0.0045
2018-02-09 2017-12-31 13F EDITAS MEDICINE COM 28106W103 2,672,556 33,664 1.28 82,129 29.62 0.0039
2017-11-14 2017-09-30 13F EDITAS MEDICINE COM 28106W103 2,638,892 106,894 4.22 63,361 49.13 0.0032
2017-08-10 2017-06-30 13F EDITAS MEDICINE COM 28106W103 2,531,998 1,413,510 126.38 42,488 70.18 0.0023
2017-05-12 2017-03-31 13F EDITAS MEDICINE COM 28106W103 1,118,488 1,118,228 430,087.69 24,966 624,050.00 0.0014
2017-02-10 2016-12-31 13F EDITAS MEDICINE COM 28106W103 260 0 0.00 4 0.00 0.0000
2016-11-08 2016-09-30 13F EDITAS MEDICINE COM 28106W103 260 0 0.00 4 -33.33 0.0000
2016-08-10 2016-06-30 13F EDITAS MEDICINE COM 28106W103 260 0 0.00 6 -33.33 0.0000
2016-05-10 2016-03-31 13F EDITAS MEDICINE COM 28106W103 260 260 9 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.